Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Expecting 10 Biosimilar Applications Submitted By End Of FY 2015

Aug 11 2014

• By Derrick Gingery

Related Content

FDA Sets Biosimilar Application Fees, But Is Silent On Volume Projections

Jul 31 2012

Biosimilars: Does Low BsUFA Fee Revenue Suggest Sponsor Interest Has Stalled?

Apr 08 2013

How To Get A Meeting With FDA: Guidance Describes Formal Meetings For Biosimilars

Mar 29 2013

Biosimilars Program Will Be “Under-Resourced” In Early Years As Industry Grows

Sep 13 2012

Related Companies

Novartis AG

Amgen, Inc.

Additional Topics

United States Regulation Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window